Cargando…

Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss

BACKGROUND: We have recently shown that serum relaxin-2 levels are attenuated in women with a history of recurrent pregnancy loss (RPL). We sought to determine whether a history of RPL is also associated with changes in serum matrix metalloproteases (MMPs) and tissue inhibitors of matrix metalloprot...

Descripción completa

Detalles Bibliográficos
Autores principales: Anumba, Dilly OC, El Gelany, Saad, Elliott, Sarah L, Li, Tin C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901309/
https://www.ncbi.nlm.nih.gov/pubmed/20565712
http://dx.doi.org/10.1186/1477-7827-8-62
_version_ 1782183670269870080
author Anumba, Dilly OC
El Gelany, Saad
Elliott, Sarah L
Li, Tin C
author_facet Anumba, Dilly OC
El Gelany, Saad
Elliott, Sarah L
Li, Tin C
author_sort Anumba, Dilly OC
collection PubMed
description BACKGROUND: We have recently shown that serum relaxin-2 levels are attenuated in women with a history of recurrent pregnancy loss (RPL). We sought to determine whether a history of RPL is also associated with changes in serum matrix metalloproteases (MMPs) and tissue inhibitors of matrix metalloproteases (TIMP) -1 and -2. METHODS: We obtained serum from 20 pregnant women with a history of RPL and 20 age-matched pregnant women with no history of RPL (NRPL) at 6-8, 10-12, 20, and 34 weeks gestation, and from cord blood. We quantified total serum concentrations of MMP-1, MMP-3, MMP-9 and TIMP-1 and TIMP-2 by ELISA. We determined whether these serum marker levels were associated with a history of RPL and delivery before 37 weeks gestation. RESULTS: There was no difference in the rates of miscarriage, preterm birth or prelabour rupture of fetal membranes between RPL and NRPL. However babies born to RPL were lighter than those born to NRPL. Serum MMP-1, 9, and TIMP-1 did not differ between RPL and NRPL but MMP-3 was higher in RPL vs. NRPL at 6-8 weeks (P < 0.05). Serum TIMP-2 levels were higher in RPL women at all gestations (P < 0.01). The ratio of RLX-2 (reported previously) to TIMP-2 at 10-12 weeks gestation was more strongly associated with a history of RPL than either peptide separately - area under the ROC curves for RLX-2 0.79 (95% CI 0.57 to 0.92), TIMP-2 0.83 (95% CI 0.63 to 0.95), and for RLX-2:TIMP-2 ratio 0.92 (95% CI 0.74 to 0.99). CONCLUSIONS: Women with a history of RPL demonstrate increased serum TIMP-2 and reduced RLX-2 during a subsequent viable pregnancy. Determination of both markers in early pregnancy enhances the discrimination of women with a history of RPL. These observations suggest roles for these two peptides in early implantation and placental development. Whether these may prove to be reliable early predictive markers for subsequent pregnancy loss in the index pregnancy is unknown and will require further studies.
format Text
id pubmed-2901309
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29013092010-07-10 Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss Anumba, Dilly OC El Gelany, Saad Elliott, Sarah L Li, Tin C Reprod Biol Endocrinol Research BACKGROUND: We have recently shown that serum relaxin-2 levels are attenuated in women with a history of recurrent pregnancy loss (RPL). We sought to determine whether a history of RPL is also associated with changes in serum matrix metalloproteases (MMPs) and tissue inhibitors of matrix metalloproteases (TIMP) -1 and -2. METHODS: We obtained serum from 20 pregnant women with a history of RPL and 20 age-matched pregnant women with no history of RPL (NRPL) at 6-8, 10-12, 20, and 34 weeks gestation, and from cord blood. We quantified total serum concentrations of MMP-1, MMP-3, MMP-9 and TIMP-1 and TIMP-2 by ELISA. We determined whether these serum marker levels were associated with a history of RPL and delivery before 37 weeks gestation. RESULTS: There was no difference in the rates of miscarriage, preterm birth or prelabour rupture of fetal membranes between RPL and NRPL. However babies born to RPL were lighter than those born to NRPL. Serum MMP-1, 9, and TIMP-1 did not differ between RPL and NRPL but MMP-3 was higher in RPL vs. NRPL at 6-8 weeks (P < 0.05). Serum TIMP-2 levels were higher in RPL women at all gestations (P < 0.01). The ratio of RLX-2 (reported previously) to TIMP-2 at 10-12 weeks gestation was more strongly associated with a history of RPL than either peptide separately - area under the ROC curves for RLX-2 0.79 (95% CI 0.57 to 0.92), TIMP-2 0.83 (95% CI 0.63 to 0.95), and for RLX-2:TIMP-2 ratio 0.92 (95% CI 0.74 to 0.99). CONCLUSIONS: Women with a history of RPL demonstrate increased serum TIMP-2 and reduced RLX-2 during a subsequent viable pregnancy. Determination of both markers in early pregnancy enhances the discrimination of women with a history of RPL. These observations suggest roles for these two peptides in early implantation and placental development. Whether these may prove to be reliable early predictive markers for subsequent pregnancy loss in the index pregnancy is unknown and will require further studies. BioMed Central 2010-06-16 /pmc/articles/PMC2901309/ /pubmed/20565712 http://dx.doi.org/10.1186/1477-7827-8-62 Text en Copyright ©2010 Anumba et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Anumba, Dilly OC
El Gelany, Saad
Elliott, Sarah L
Li, Tin C
Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss
title Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss
title_full Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss
title_fullStr Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss
title_full_unstemmed Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss
title_short Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss
title_sort circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901309/
https://www.ncbi.nlm.nih.gov/pubmed/20565712
http://dx.doi.org/10.1186/1477-7827-8-62
work_keys_str_mv AT anumbadillyoc circulatinglevelsofmatrixproteasesandtheirinhibitorsinpregnantwomenwithandwithoutahistoryofrecurrentpregnancyloss
AT elgelanysaad circulatinglevelsofmatrixproteasesandtheirinhibitorsinpregnantwomenwithandwithoutahistoryofrecurrentpregnancyloss
AT elliottsarahl circulatinglevelsofmatrixproteasesandtheirinhibitorsinpregnantwomenwithandwithoutahistoryofrecurrentpregnancyloss
AT litinc circulatinglevelsofmatrixproteasesandtheirinhibitorsinpregnantwomenwithandwithoutahistoryofrecurrentpregnancyloss